Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Mol Cancer Ther. 2018 Sep 11;17(11):2481–2489. doi: 10.1158/1535-7163.MCT-18-0156

Fig. 6.

Fig. 6.

Subcutaneous tumor growth of NSCLC, ovarian and endometrial cells in SDR rats. (A) H358 cancer cells were transplanted subcutaneously in the SDR rat. Three groups of six rats received either 1×106, 5×106 or 1×107 cells in 5mg/ml Geltrex. In comparison, 1×107 H358 cells were injected in six nude and six NSG mice and growth was tracked for 60 days. Average tumor growth (mm3) over time. (B) 2×106 OV81 cells resuspended in 5mg/ml Geltrex were injected subcutaneously into three female SDR rats. Graph shows three individual rat tumor volumes over time (mm3). Each line represents tumor growth in an individual rat. (C) 2×106 OV185 cells resuspended in 5mg/ml Geltrex were injected subcutaneously into two female SDR rats. Graph shows two individual rat tumor volumes over time (mm3). Each line represents tumor growth in an individual rat.